-
1
المؤلفون: Gaëlle Farge, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sheenu Chandwani, Caroline Dutriaux, Sophie Dalac, Laurie Levy-Bachelot, Laetitia Verdoni, Emilie Scherrer, Clara Allayous, Céleste Lebbé, Emilie Casarotto, B. Oriano
المساهمون: MSD France, Merck & Co. Inc, CHU Lille, Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Saint-André, CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
المصدر: Immunotherapy
Immunotherapy, 2021, 13 (11), pp.905-916. ⟨10.2217/imt-2021-0077⟩مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Skin Neoplasms, Databases, Factual, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Pembrolizumab, Antibodies, Monoclonal, Humanized, computer.software_genre, Tumor response, survival, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, cohort study, medicine, Overall survival, Humans, Immunology and Allergy, Stage (cooking), Immune Checkpoint Inhibitors, Melanoma, Aged, Advanced melanoma, Aged, 80 and over, Database, business.industry, Immunotherapy, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, immunotherapy, pembrolizumab, France, business, computer, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eeecf15ac2f76c4e915b9fc7920c053Test
https://doi.org/10.2217/imt-2021-0077Test -
2
المؤلفون: Victoria Wurcel, Juan Ignacio Altuna, Fernando Carabajal, Gargi Baluni, Raquel Aguiar-Ibáñez, Shrishti Jain, Emilie Scherrer
المصدر: Oncology and Therapy
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Cost effectiveness, Melanoma, medicine.medical_treatment, Hazard ratio, Argentina, Pembrolizumab, Adjuvant treatment, medicine.disease, Confidence interval, Latin America, Internal medicine, Medicine, Cost-effectiveness, Stage (cooking), business, health care economics and organizations, Reimbursement, Watchful waiting, Original Research
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ffa07f0b556a00966d5479d4441a82Test
https://doi.org/10.1007/s40487-021-00142-8Test -
3
المؤلفون: Charles Lance Cowey, Emilie Scherrer, April Beeks, Clemens Krepler, Marley Boyd, Kathleen M. Aguilar
المصدر: Cancer Medicine, Vol 9, Iss 21, Pp 7863-7878 (2020)
Cancer Medicineمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, Programmed Cell Death 1 Receptor, Medical Oncology, immunology, 0302 clinical medicine, Risk Factors, Medicine, Community Health Services, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Original Research, Community based, Aged, 80 and over, Middle Aged, MAP Kinase Kinase Kinases, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Drug Utilization, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, First line, Risk Assessment, survival, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, Protein Kinase Inhibitors, Advanced melanoma, Aged, Retrospective Studies, Adult patients, business.industry, target therapy, Clinical Cancer Research, biomarkers, Retrospective cohort study, 030104 developmental biology, Propensity score matching, Mutation, Observational study, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fc6bc46c16e1f918585ef9a89a846dTest
https://doaj.org/article/ee976dd75d584d12914c8df2bc5510e8Test -
4
المؤلفون: Steven M. Townson, James Larkin, Emilie Scherrer, Reina Rau, Irene Shui, Maria Lorenzi
المصدر: Future oncology (London, England). 17(20)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, Clinical Decision-Making, Programmed Cell Death 1 Receptor, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Overall survival, Biomarkers, Tumor, Humans, Immune Checkpoint Inhibitors, Melanoma, Advanced melanoma, business.industry, Patient Selection, Anti pd 1, General Medicine, medicine.disease, Progression-Free Survival, 030104 developmental biology, Systematic review, 030220 oncology & carcinogenesis, Biomarker (medicine), business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c394dfb2529278b1dd27e417d8c10cTest
https://pubmed.ncbi.nlm.nih.gov/33783230Test -
5
المؤلفون: Xiaoyun Li, Cathy Anne Pinto, Emilie Scherrer, Mizuho Kalabis, Xinyue Liu
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
مصطلحات موضوعية: medicine.medical_specialty, Chemotherapy, Combination therapy, business.industry, medicine.medical_treatment, Medical record, Disease progression, Pembrolizumab, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Stable Disease, Internal medicine, medicine, Nivolumab, business, Social Security Death Index
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a08aa4a18c0690b927dab1976b7af3Test
https://doaj.org/article/1bfc61267f7a45059e87b4fee703575bTest -
6
المؤلفون: Anvi Khandelwal, Baanie Sawhney, John Cook, Emilie Scherrer, Shalini Bagga, Raquel Aguiar-Ibáñez, Dmitri Grebennik, Scott Soefje
المصدر: Journal for ImmunoTherapy of Cancer. 9:A941-A941
مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, Schedule, business.industry, Melanoma, medicine.medical_treatment, Immunology, Pembrolizumab, medicine.disease, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, Dosing, business, Adjuvant
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7af1f3e3202f213bbd013952090a7809Test
https://doi.org/10.1136/jitc-2021-sitc2021.897Test -
7
المؤلفون: Emilie Scherrer, Eric Druyts, Hussein Tawbi, Irene Shui, Andrew Frederickson
المصدر: Journal for ImmunoTherapy of Cancer. 9:A339-A339
مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Immunology, Anti pd 1, Immunotherapy, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, business, Advanced melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c80f3173bbaed1027f6f5053ec9ed425Test
https://doi.org/10.1136/jitc-2021-sitc2021.315Test -
8
المؤلفون: Arielle G. Bensimon, Wei Gao, Madeline Jenkins, Emilie Scherrer, James Signorovitch, Raquel Aguiar-Ibáñez, Zheng-Yi Zhou, Clemens Krepler, Jingshu Wang, Yan Song
المصدر: Clinical Drug Investigation
مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, medicine.medical_treatment, Cost-Benefit Analysis, Population, Ipilimumab, Pembrolizumab, 030204 cardiovascular system & hematology, Placebo, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, Adverse effect, education, Melanoma, Neoplasm Staging, Trametinib, education.field_of_study, business.industry, Dabrafenib, General Medicine, Health Care Costs, Middle Aged, Female, Quality-Adjusted Life Years, business, Adjuvant, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc665ba8e733bfe3fa1a444a1858bd33Test
https://pubmed.ncbi.nlm.nih.gov/32418051Test -
9
المؤلفون: Emilie Scherrer, Wanmei Ou, Eric D. Whitman, Clemens Krepler
المصدر: Future oncology (London, England). 16(20)
مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, medicine, Humans, In patient, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Anti pd 1, Retrospective cohort study, General Medicine, Immunotherapy, Middle Aged, medicine.disease, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, Retreatment, Female, Outcomes research, business, Progressive disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ecb7e4b6384a254b88279aeefff942cTest
https://pubmed.ncbi.nlm.nih.gov/32410465Test -
10
المؤلفون: Emilie Scherrer, Rachael Miller, Agnes Brandtmüller, Kevin Cadwell, Irene Shui, Sophie Walker
المصدر: Melanoma Management
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, skin (melanoma), MEDLINE, Review, Dermatology, Disease, survival, cutaneous melanoma, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Epidemiology, medicine, Adjuvant therapy, cancer, Stage (cooking), business.industry, Incidence (epidemiology), Cancer, adjuvant therapy, staging, medicine.disease, mortality, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, incidence, epidemiology, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5f4697850e66ab1ac2440612678698Test
https://doi.org/10.2217/mmt-2019-0022Test